Mark Waring

669 total citations
9 papers, 472 citations indexed

About

Mark Waring is a scholar working on Molecular Biology, Surgery and Pathology and Forensic Medicine. According to data from OpenAlex, Mark Waring has authored 9 papers receiving a total of 472 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Surgery and 2 papers in Pathology and Forensic Medicine. Recurrent topics in Mark Waring's work include Pancreatic function and diabetes (3 papers), Adenosine and Purinergic Signaling (2 papers) and Ion channel regulation and function (2 papers). Mark Waring is often cited by papers focused on Pancreatic function and diabetes (3 papers), Adenosine and Purinergic Signaling (2 papers) and Ion channel regulation and function (2 papers). Mark Waring collaborates with scholars based in Germany and Australia. Mark Waring's co-authors include Graham Kelly, Carolyn Nelson, George E. Joannou, Anthony Y. Reeder, Frank Andersohn, Edeltraut Garbe, Christof Schöfl, J. B. Howes, L. G. Howes and A. von zur Mühlen and has published in prestigious journals such as FEBS Letters, Endocrinology and American Journal of Physiology-Endocrinology and Metabolism.

In The Last Decade

Mark Waring

9 papers receiving 455 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Waring Germany 8 250 148 113 98 97 9 472
Zhiwen Yu China 11 66 0.3× 52 0.4× 199 1.8× 140 1.4× 37 0.4× 14 555
Radivoj Kocić Serbia 9 85 0.3× 31 0.2× 118 1.0× 145 1.5× 40 0.4× 25 403
Kazuya Muranaka Japan 9 82 0.3× 32 0.2× 118 1.0× 86 0.9× 78 0.8× 12 424
Kirsten Heitmann Germany 3 152 0.6× 31 0.2× 170 1.5× 362 3.7× 82 0.8× 5 844
C.M. McVicar United Kingdom 9 55 0.2× 40 0.3× 200 1.8× 158 1.6× 45 0.5× 12 839
Mark Bouwens Netherlands 7 35 0.1× 72 0.5× 177 1.6× 41 0.4× 200 2.1× 9 537
H.A. Peredo Argentina 14 37 0.1× 122 0.8× 91 0.8× 134 1.4× 24 0.2× 47 508
Karina B. Cullberg Denmark 9 62 0.2× 32 0.2× 144 1.3× 28 0.3× 92 0.9× 9 479
Urszula Cegieła Poland 12 66 0.3× 39 0.3× 175 1.5× 87 0.9× 20 0.2× 45 423
Jason J. Yuen United States 12 84 0.3× 41 0.3× 399 3.5× 88 0.9× 59 0.6× 13 685

Countries citing papers authored by Mark Waring

Since Specialization
Citations

This map shows the geographic impact of Mark Waring's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Waring with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Waring more than expected).

Fields of papers citing papers by Mark Waring

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Waring. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Waring. The network helps show where Mark Waring may publish in the future.

Co-authorship network of co-authors of Mark Waring

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Waring. A scholar is included among the top collaborators of Mark Waring based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Waring. Mark Waring is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Andersohn, Frank, Mark Waring, & Edeltraut Garbe. (2009). Risk of ischemic stroke in patients with Crohnʼs disease. Inflammatory Bowel Diseases. 16(8). 1387–1392. 74 indexed citations
2.
Düfer, Martina, Gisela Drews, Mark Waring, et al.. (2003). Palmitate-induced Ca2+-signaling in pancreatic beta-cells. Molecular and Cellular Endocrinology. 212(1-2). 1–9. 34 indexed citations
3.
Howes, J. B., et al.. (2002). Long-Term Pharmacokinetics of an Extract of Isoflavones from Red Clover ( Trifolium pratense ). The Journal of Alternative and Complementary Medicine. 8(2). 135–142. 36 indexed citations
4.
Schöfl, Christof, Mark Waring, Clemens Bergwitz, et al.. (2002). Cyclic-adenosine 3′,5′-monophosphate-stimulated c-fos gene transcription involves distinct calcium pathways in single β-cells. Molecular and Cellular Endocrinology. 186(1). 121–131. 6 indexed citations
5.
Schöfl, Christof, et al.. (2000). Tolbutamide and diazoxide modulate phospholipase C-linked Ca2+signaling and insulin secretion in β-cells. American Journal of Physiology-Endocrinology and Metabolism. 278(4). E639–E647. 9 indexed citations
6.
Waring, Mark, Jan Drappatz, Oksana Weichel, et al.. (1999). Modulation of neuronal phospholipase D activity under depolarizing conditions. FEBS Letters. 464(1-2). 21–24. 19 indexed citations
7.
Schöfl, Christof, Mark Waring, Peter Krippeit‐Drews, et al.. (1999). Ca2+/Calmodulin Inhibition and Phospholipase C-Linked Ca2+ Signaling in Clonalβ -Cells1. Endocrinology. 140(12). 5516–5523. 10 indexed citations
8.
Schöfl, Christof, Mark Waring, Heike Benecke, et al.. (1999). Regulation of cytosolic free calcium concentration by extracellular nucleotides in human hepatocytes. American Journal of Physiology-Gastrointestinal and Liver Physiology. 276(1). G164–G172. 46 indexed citations
9.
Kelly, Graham, Carolyn Nelson, Mark Waring, George E. Joannou, & Anthony Y. Reeder. (1993). Metabolites of dietary (soya) isoflavones in human urine. Clinica Chimica Acta. 223(1-2). 9–22. 238 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026